Bepotastine

From WikiMD.org
Jump to navigation Jump to search

Bepotastine

Bepotastine (pronunciation: be-po-tas-tine) is a second generation antihistamine intended for the management of allergies. It was approved by the FDA in September 2009.

Etymology

The term "Bepotastine" is derived from its chemical name, which is (S)-4-(4-((4-chlorophenyl)(2-pyridyl)methoxy)piperidino) butyric acid. The prefix "Be-" is derived from "butyric acid", "-pota-" from "piperidino", and "-stine" from "antihistamine".

Usage

Bepotastine is used for the treatment of pruritus (itching) associated with dermatitis and urticaria (hives), and for the treatment of rhinitis (inflammation of the nasal passages). It is also used in eye drop form for the treatment of ocular itching associated with allergic conjunctivitis.

Mechanism of Action

Bepotastine works by blocking the action of histamine, a substance in the body that causes allergic symptoms. It is a highly selective histamine H1 receptor antagonist.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski